In Brief: BioSource International
This article was originally published in The Gray Sheet
Executive Summary
BioSource International: Plans restructuring of BioSource Europe, S.A., headquartered in Fleurus, Belgium to "eliminate research and development functions which are duplicative of the company's United States operations." The move is necessary because integration efforts following the firm's acquisition of Medgenix Diagnostics "have not sufficiently reduced the duplication of effort" that exists with U.S. operations, BioSource says. The company also plans to move from a direct sales strategy in Italy to an exclusive distributor arrangement...